Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boulder, CO
SEC filing record 1 source field available
Fiscal year end
31 December
Edgewise Therapeutics, Inc. has filed 400 SEC EDGAR filings since 26 Sep 2019

SEC filing history

Showing 226-250 of 400 matching filings.

Per page
25
Current page
10
424B5 File 333-264083

424B5

Filing date
16 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jun 2023
Reporting date
12 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jun 2023
Reporting date
12 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jun 2023
Reporting date
12 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jun 2023
Reporting date
12 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jun 2023
Reporting date
12 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-271836

FORM S-8

Filing date
11 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40236

EDGEWISE THERAPEUTICS, INC. 8-K

Filing date
11 May 2023
Reporting date
11 May 2023
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 May 2023
Reporting date
01 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 May 2023
Reporting date
01 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 May 2023
Reporting date
01 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 May 2023
Reporting date
01 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 May 2023
Reporting date
01 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 May 2023
Reporting date
01 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-40236

ARS

Filing date
28 Apr 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-40236

DEFA14A

Filing date
28 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-40236

DEF 14A

Filing date
28 Apr 2023
Reporting date
09 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Mar 2023
Reporting date
03 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
07 Mar 2023
Reporting date
02 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40236

EDGEWISE THERAPEUTICS, INC. 8-K

Filing date
23 Feb 2023
Reporting date
23 Feb 2023
Next action
Verify source filing
SC 13G/A File 005-92424

SC 13G/A filing

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .